ACIP Final – June 26, 2014

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia

June 25-26, 2014 

AGENDA ITEM PURPOSE PRESIDER/PRESENTER(s)

Wednesday, June 25th

8:00

 

Welcome & Introductions Dr Jonathan Temte (Chair, ACIP)

Dr Larry Pickering (Executive Secretary, 

ACIP, CDC)

8:30 General Recommendations

• Introduction

• Vaccination of persons with altered immunocompetence

• Vaccination programs

Information

Discussion

Dr Jeff Duchin (ACIP, WG Chair) 

Dr Andrew Kroger (CDC/NCIRD) 

Dr Andrew Kroger (CDC/NCIRD)

9:15 Child/Adolescent Immunization

• Introduction

• Healthcare provider review of 2014 catch-up schedule and 

supplementary tables

Information

Discussion

Dr Renée Jenkins (ACIP, WG Chair)

Dr Andrew Kroger (CDC/NCIRD)

9:35 Yellow Fever Vaccine

• Introduction

• GRADE and Work Group conclusions regarding yellow fever 

vaccine booster dose

Information

Discussion

Vote

Dr Joseph Bocchini (ACIP, WG Chair)

Dr Erin Staples (CDC.NCEZID)

10:35 Break

11:00 Influenza

• Introduction

• Novel Influenza Vaccine Work Group

• Influenza vaccine safety update

• Assessing fever rates in children following LAIV and IIV

• LAIV and IIV vaccine safety

• Proposed recommendations

Information

Discussion

Vote

Dr Ruth Karron (ACIP,WG Chair)

Dr Doug Campos-Outcalt (ACIP, WG Chair)

Dr Maria Cano (CDC/NCEZID)

Dr Melissa Stockwell (Columbia University)

Dr Lisa Grohskopf (CDC/NCIRD)

Dr Lisa Grohskopf (CDC/NCIRD)

12:30 Lunch

1:45 Human Papillomavirus (HPV) Vaccines

• Introduction

• 9-valent HPV vaccine clinical trial data

• 9-valent HPV vaccine: overview of WG considerations

• 2-dose HPV vaccine schedules: review of data

• HPV Vaccines Work Group plans

Information

Discussion

Dr Joseph Bocchini (ACIP, WG Chair)

Dr Alain Luxembourg (Merck)

Dr Eileen Dunne (CDC/NCHHSTP)

Dr Lauri Markowitz (CDC/NCHHSTP)

Dr Lauri Markowitz (CDC/NCHHSTP)

3:15 Break

3:45 Vaccine Safety

• Introduction

• Febrile seizures after administration of trivalent influenza 

vaccines – PRISM system, 2010-2011 influenza season

• Seizures following administration of multiple vaccines: a 

VSD study

• Summary

Information

Discussion

Dr Tom Shimabukuro (CDC/NCEZID)

Dr Alison Kawai (Harvard Medical School, 

Harvard Pilgrim Health Care Institute)

Dr Jonathan Duffy (CDC/NCEZID)

Dr Tom Shimabukuro (CDC/NCEZID)

5:00 Adult Immunization

• Introduction

• Update on adult immunization coverage

• Update on CDC’s adult immunization communication 

activities

Information

Discussion

Dr Tamera Coyne-Beasley (ACIP, WG Chair)

Dr Walter Williams (CDC/NCIRD)

Dr Kristine Sheedy (CDC/NCIRD)

5:45 Public Comment

6:00 Adjourn

Page 1 of 2 
ACIP Final – June 26, 2014

AGENDA ITEM PURPOSE PRESIDER/PRESENTER(s)

Thursday, June 26th

8:00 Updates

• Typhoid Vaccines

• Agency Updates: CDC and ACIP Ex Officio Members

 CMS, DoD, DVA FDA, HRSA, IHS, NVPO, NIH

Information

Dr Brendan Jackson (CDC/NCEZID)

8:15 13-Valent Pneumococcal Conjugate Vaccine 

• Introduction & update on 3-dose schedule for infants

• PCV13 efficacy among adults: results of CAPiTA study

• Potential public health impact and cost-effectiveness of 

PCV13 use in adults

• Considerations for PCV13 use among adults and policy 

options

Information

Discussion 

Dr Nancy Bennett (ACIP, WG Chair)

Dr Rosalind Hollingsworth, (Global Medical 

Lead, Pfizer) 

Dr Charles Stoecker (Tulane University, 

School of Public Health)

Dr Tamara Pilishvili (CDC/NCIRD)

9:55 Vaccine Supply Information Dr Jeanne Santoli (CDC/NCIRD)

10:00 Measles Update

• Global update

• Domestic update

Information

Discussion

Mr Jim Goodson (CDC/CGH/GID)

Dr Greg Wallace (CDC/NCIRD)

10:45 Break

11:00 Meningococcal Vaccines

• Introduction

• Epidemiology of meningococcal disease outbreaks in the 

United States

• Interim guidance for the use of serogroup B meningococcal 

vaccines under a CDC-sponsored IND 

Information

Discussion

Dr Lorry Rubin (ACIP, WG Chair)

Dr Sarah Meyer (CDC/NCIRD)

Ms Jessica MacNeil (CDC/NCIRD)

12:00 Hepatitis Vaccines

• Update: ACIP Hepatitis Work Group Information Dr Art Reingold (ACIP, WG Chair)

1:15 Public Comment

1:30 Adjourn

Acronyms

CDC Centers for Disease Control & Prevention

CMS Centers for Medicare and Medicaid Services 

DOD Department of Defense

DVA Department of Veterans Affairs

FDA Food and Drug Administration

GRADE Grading of Recommendations Assessment, Development and Evaluation

HRSA Health Resources and Services Administration

IHS Indian Health Service

IIV Inactivated Influenza Vaccine

IND Investigational New Drug

IHS

LAIV

Indian Health Service

Live-Attenuated Influenza Vaccine

NCHHSTP National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

NCIRD CDC National Center for Immunization & Respiratory Diseases [of CDC/OID] 

NCZVED National Center for Zoonotic, Vector-Borne, and Enteric Diseases [of CDC/OID]

NIH National Institutes of Health

NVPO National Vaccine Program Office

WG Work Group

Page 2 of 2